RSV drug for infants gets FDA approval
The FDA has given the green light to the single-injection Beyfortus, saying it can prevent RSV in children up to 24 months old for an entire season. CBS News Bay Area anchor Ryan Yamamoto asks Dr. Yvonne Maldonado, epidemiologist and infectious disease specialist at Stanford Health Care, about how it works, and how safe it is